au.\*:("MOORMAN, Anthony V")
Results 1 to 25 of 38
Selection :
The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemiaMOORMAN, Anthony V.Blood reviews. 2012, Vol 26, Num 3, pp 123-135, issn 0268-960X, 13 p.Article
Sex ratios and the risks of haematological malignanciesCARTWRIGHT, Ray A; GURNEY, Karen A; MOORMAN, Anthony V et al.British journal of haematology. 2002, Vol 118, Num 4, pp 1071-1077, issn 0007-1048Article
Incidence of childhood acute lymphoblastic leukaemia in Yorkshire, UKFELTBOWER, Richard G; MOORMAN, Anthony V; DOVEY, Gareth et al.Lancet (British edition). 2001, Vol 358, Num 9279, pp 385-387, issn 0140-6736Article
Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12HARRISON, Christine J; HILLS, Robert K; GIBSON, Brenda E. S et al.Journal of clinical oncology. 2010, Vol 28, Num 16, pp 2674-2681, issn 0732-183X, 8 p.Article
Methylation of tumour suppressor gene promoters in the presence and absence of transcriptional silencing in high hyperdiploid acute lymphoblastic leukaemiaPAULSSON, Kajsa; QIAN AN; YOUNG, Bryan D et al.British journal of haematology. 2009, Vol 144, Num 6, pp 838-847, issn 0007-1048, 10 p.Article
Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia : a UK Cancer Cytogenetics Group StudyHARRISON, Christine J; MOORMAN, Anthony V; WRIGHT, Sarah et al.British journal of haematology. 2005, Vol 129, Num 4, pp 520-530, issn 0007-1048, 11 p.Article
Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groupsATTARBASCHI, Andishe; MORAK, Maria; SCHWAB, Claire et al.British journal of haematology. 2012, Vol 158, Num 6, pp 772-777, issn 0007-1048, 6 p.Article
Genetic variegation of clonal architecture and propagating cells in leukaemiaANDERSON, Kristina; LUTZ, Christoph; KEARNEY, Lyndal et al.Nature (London). 2011, Vol 469, Num 7330, pp 356-361, issn 0028-0836, 6 p.Article
Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trialsWHEATLEY, Keith; BROOKES, Cassandra L; HOWMAN, Andrew J et al.British journal of haematology. 2009, Vol 145, Num 5, pp 598-605, issn 0007-1048, 8 p.Article
Sequential Influences of Leukemia-Specific and Genetic Factors on P-Glycoprotein Expression in Blasts from 817 Patients Entered into the National Cancer Research Network Acute Myeloid Leukemia 14 and 15 TrialsSEEDHOUSE, Claire H; GRUNDY, Martin; PALLIS, Monica et al.Clinical cancer research. 2007, Vol 13, Num 23, pp 7059-7066, issn 1078-0432, 8 p.Article
Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemiaHARRISON, Christine J; MOORMAN, Anthony V; EDEN, Tim O. B et al.British journal of haematology. 2004, Vol 125, Num 5, pp 552-559, issn 0007-1048, 8 p.Article
Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocolPATRICK, Katharine; WADE, Rachel; GOULDEN, Nicholas et al.British journal of haematology. 2014, Vol 165, Num 4, pp 552-555, issn 0007-1048, 4 p.Article
Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993PATEL, Bella; RAI, Lena; FIELDING, Adele K et al.British journal of haematology. 2010, Vol 148, Num 1, pp 80-89, issn 0007-1048, 10 p.Article
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trialsGRIMWADE, David; HILLS, Robert K; MOORMAN, Anthony V et al.Blood. 2010, Vol 116, Num 3, pp 354-365, issn 0006-4971, 12 p.Article
Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trialPARKER, Catriona; WATERS, Rachel; GREEN, Nina et al.Lancet (British edition). 2010, Vol 376, Num 9757, pp 2009-2017, issn 0140-6736, 9 p.Article
Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)MOORMAN, Anthony V; RICHARDS, Susan M; ROBINSON, Hazel M et al.Blood. 2007, Vol 109, Num 6, pp 2327-2330, issn 0006-4971, 4 p.Article
IGH@ Translocations Are Prevalent in Teenagers and Young Adults With Acute Lymphoblastic Leukemia and Are Associated With a Poor OutcomeRUSSELL, Lisa J; ENSHAEI, Amir; MITCHELL, Christopher D et al.Journal of clinical oncology. 2014, Vol 32, Num 14, pp 1453-1462, issn 0732-183X, 10 p.Article
IGH@ Translocations, CRLF2 Deregulation, and Microdeletions in Adolescents and Adults With Acute Lymphoblastic LeukemiaMOORMAN, Anthony V; SCHWAB, Claire; GOLDSTONE, Anthony H et al.Journal of clinical oncology. 2012, Vol 30, Num 25, pp 3100-3108, issn 0732-183X, 9 p.Article
Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trialENSOR, Hannah M; SCHWAB, Claire; HARRISON, Christine J et al.Blood. 2011, Vol 117, Num 7, pp 2129-2136, issn 0006-4971, 8 p.Article
Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemiaRAND, Vikki; PARKER, Helen; RYAN, Sarra et al.Blood. 2011, Vol 117, Num 25, pp 6848-6855, issn 0006-4971, 8 p.Article
Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell-origin of ALL subgroups - a UKALLXII studyRAI, Lena; CASANOVA, Anouska; MOORMAN, Anthony V et al.British journal of haematology. 2010, Vol 148, Num 3, pp 394-401, issn 0007-1048, 8 p.Article
Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia riskSHERBORNE, Amy L; HOSKING, Fay J; GAST, Andreas et al.Nature genetics. 2010, Vol 42, Num 6, pp 492-494, issn 1061-4036, 3 p.Article
RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 yearsBOWEN, David T; FREW, Marion E; LINCH, David C et al.Blood. 2005, Vol 106, Num 6, pp 2113-2119, issn 0006-4971, 7 p.Article
Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003PATRICK, Katharine; WADE, Rachel; GOULDEN, Nick et al.British journal of haematology. 2014, Vol 166, Num 3, pp 421-424, issn 0007-1048, 4 p.Article
Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivityTHATHIA, Shabnam H; FERGUSON, Stuart; GAUTREY, Hannah E et al.Haematologica (Roma). 2012, Vol 97, Num 3, pp 371-378, issn 0390-6078, 8 p.Article